Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]Code Contextif (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5661582929-trace').style.display = (document.getElementById('cakeErr67f5661582929-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f5661582929-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5661582929-code').style.display = (document.getElementById('cakeErr67f5661582929-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5661582929-context').style.display = (document.getElementById('cakeErr67f5661582929-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f5661582929-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67f5661582929-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 20268, 'title' => 'Indian patent rulings may face legal heat internationally -Soma Das', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times </div> <p align="justify"> <br /> The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. </p> <p align="justify"> An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists. </p> <p align="justify"> &quot;The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights,&quot; said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh. </p> <p align="justify"> Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor. </p> <p align="justify"> Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug. </p> <p align="justify"> The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid. </p> <p align="justify"> Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property. </p> <p align="justify"> Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>', 'credit_writer' => 'The Economic Times, 11 April, 2013, http://economictimes.indiatimes.com/news/economy/policy/indian-patent-rulings-may-face-legal-heat-internationally/articleshow/19486296.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20409, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 20268, 'metaTitle' => 'LATEST NEWS UPDATES | Indian patent rulings may face legal heat internationally -Soma Das', 'metaKeywords' => 'generic drugs,medicines,patents,Health', 'metaDesc' => ' -The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade...', 'disp' => '<div align="justify">-The Economic Times</div><p align="justify"><br />The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned.</p><p align="justify">An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists.</p><p align="justify">&quot;The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights,&quot; said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh.</p><p align="justify">Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor.</p><p align="justify">Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug.</p><p align="justify">The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid.</p><p align="justify">Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property.</p><p align="justify">Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 20268, 'title' => 'Indian patent rulings may face legal heat internationally -Soma Das', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times </div> <p align="justify"> <br /> The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. </p> <p align="justify"> An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists. </p> <p align="justify"> &quot;The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights,&quot; said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh. </p> <p align="justify"> Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor. </p> <p align="justify"> Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug. </p> <p align="justify"> The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid. </p> <p align="justify"> Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property. </p> <p align="justify"> Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>', 'credit_writer' => 'The Economic Times, 11 April, 2013, http://economictimes.indiatimes.com/news/economy/policy/indian-patent-rulings-may-face-legal-heat-internationally/articleshow/19486296.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20409, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 20268 $metaTitle = 'LATEST NEWS UPDATES | Indian patent rulings may face legal heat internationally -Soma Das' $metaKeywords = 'generic drugs,medicines,patents,Health' $metaDesc = ' -The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade...' $disp = '<div align="justify">-The Economic Times</div><p align="justify"><br />The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned.</p><p align="justify">An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists.</p><p align="justify">&quot;The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights,&quot; said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh.</p><p align="justify">Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor.</p><p align="justify">Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug.</p><p align="justify">The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid.</p><p align="justify">Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property.</p><p align="justify">Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Indian patent rulings may face legal heat internationally -Soma Das | Im4change.org</title> <meta name="description" content=" -The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Indian patent rulings may face legal heat internationally -Soma Das</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Economic Times</div><p align="justify"><br />The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned.</p><p align="justify">An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists.</p><p align="justify">"The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights," said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh.</p><p align="justify">Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor.</p><p align="justify">Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug.</p><p align="justify">The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid.</p><p align="justify">Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property.</p><p align="justify">Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $maxBufferLength = (int) 8192 $file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php' $line = (int) 853 $message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]Code Context$response->getStatusCode(),
($reasonPhrase ? ' ' . $reasonPhrase : '')
));
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5661582929-trace').style.display = (document.getElementById('cakeErr67f5661582929-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f5661582929-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5661582929-code').style.display = (document.getElementById('cakeErr67f5661582929-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5661582929-context').style.display = (document.getElementById('cakeErr67f5661582929-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f5661582929-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67f5661582929-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 20268, 'title' => 'Indian patent rulings may face legal heat internationally -Soma Das', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times </div> <p align="justify"> <br /> The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. </p> <p align="justify"> An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists. </p> <p align="justify"> &quot;The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights,&quot; said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh. </p> <p align="justify"> Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor. </p> <p align="justify"> Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug. </p> <p align="justify"> The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid. </p> <p align="justify"> Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property. </p> <p align="justify"> Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>', 'credit_writer' => 'The Economic Times, 11 April, 2013, http://economictimes.indiatimes.com/news/economy/policy/indian-patent-rulings-may-face-legal-heat-internationally/articleshow/19486296.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20409, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 20268, 'metaTitle' => 'LATEST NEWS UPDATES | Indian patent rulings may face legal heat internationally -Soma Das', 'metaKeywords' => 'generic drugs,medicines,patents,Health', 'metaDesc' => ' -The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade...', 'disp' => '<div align="justify">-The Economic Times</div><p align="justify"><br />The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned.</p><p align="justify">An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists.</p><p align="justify">&quot;The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights,&quot; said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh.</p><p align="justify">Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor.</p><p align="justify">Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug.</p><p align="justify">The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid.</p><p align="justify">Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property.</p><p align="justify">Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 20268, 'title' => 'Indian patent rulings may face legal heat internationally -Soma Das', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times </div> <p align="justify"> <br /> The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. </p> <p align="justify"> An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists. </p> <p align="justify"> &quot;The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights,&quot; said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh. </p> <p align="justify"> Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor. </p> <p align="justify"> Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug. </p> <p align="justify"> The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid. </p> <p align="justify"> Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property. </p> <p align="justify"> Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>', 'credit_writer' => 'The Economic Times, 11 April, 2013, http://economictimes.indiatimes.com/news/economy/policy/indian-patent-rulings-may-face-legal-heat-internationally/articleshow/19486296.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20409, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 20268 $metaTitle = 'LATEST NEWS UPDATES | Indian patent rulings may face legal heat internationally -Soma Das' $metaKeywords = 'generic drugs,medicines,patents,Health' $metaDesc = ' -The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade...' $disp = '<div align="justify">-The Economic Times</div><p align="justify"><br />The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned.</p><p align="justify">An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists.</p><p align="justify">&quot;The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights,&quot; said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh.</p><p align="justify">Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor.</p><p align="justify">Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug.</p><p align="justify">The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid.</p><p align="justify">Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property.</p><p align="justify">Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Indian patent rulings may face legal heat internationally -Soma Das | Im4change.org</title> <meta name="description" content=" -The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Indian patent rulings may face legal heat internationally -Soma Das</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Economic Times</div><p align="justify"><br />The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned.</p><p align="justify">An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists.</p><p align="justify">"The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights," said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh.</p><p align="justify">Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor.</p><p align="justify">Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug.</p><p align="justify">The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid.</p><p align="justify">Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property.</p><p align="justify">Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $reasonPhrase = 'OK'header - [internal], line ?? Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]Code Context$value
), $first);
$first = false;
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5661582929-trace').style.display = (document.getElementById('cakeErr67f5661582929-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f5661582929-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5661582929-code').style.display = (document.getElementById('cakeErr67f5661582929-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5661582929-context').style.display = (document.getElementById('cakeErr67f5661582929-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f5661582929-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67f5661582929-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 20268, 'title' => 'Indian patent rulings may face legal heat internationally -Soma Das', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times </div> <p align="justify"> <br /> The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. </p> <p align="justify"> An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists. </p> <p align="justify"> &quot;The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights,&quot; said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh. </p> <p align="justify"> Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor. </p> <p align="justify"> Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug. </p> <p align="justify"> The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid. </p> <p align="justify"> Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property. </p> <p align="justify"> Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>', 'credit_writer' => 'The Economic Times, 11 April, 2013, http://economictimes.indiatimes.com/news/economy/policy/indian-patent-rulings-may-face-legal-heat-internationally/articleshow/19486296.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20409, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 20268, 'metaTitle' => 'LATEST NEWS UPDATES | Indian patent rulings may face legal heat internationally -Soma Das', 'metaKeywords' => 'generic drugs,medicines,patents,Health', 'metaDesc' => ' -The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade...', 'disp' => '<div align="justify">-The Economic Times</div><p align="justify"><br />The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned.</p><p align="justify">An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists.</p><p align="justify">&quot;The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights,&quot; said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh.</p><p align="justify">Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor.</p><p align="justify">Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug.</p><p align="justify">The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid.</p><p align="justify">Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property.</p><p align="justify">Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 20268, 'title' => 'Indian patent rulings may face legal heat internationally -Soma Das', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times </div> <p align="justify"> <br /> The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. </p> <p align="justify"> An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists. </p> <p align="justify"> &quot;The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights,&quot; said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh. </p> <p align="justify"> Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor. </p> <p align="justify"> Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug. </p> <p align="justify"> The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid. </p> <p align="justify"> Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property. </p> <p align="justify"> Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>', 'credit_writer' => 'The Economic Times, 11 April, 2013, http://economictimes.indiatimes.com/news/economy/policy/indian-patent-rulings-may-face-legal-heat-internationally/articleshow/19486296.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20409, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 20268 $metaTitle = 'LATEST NEWS UPDATES | Indian patent rulings may face legal heat internationally -Soma Das' $metaKeywords = 'generic drugs,medicines,patents,Health' $metaDesc = ' -The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade...' $disp = '<div align="justify">-The Economic Times</div><p align="justify"><br />The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned.</p><p align="justify">An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists.</p><p align="justify">&quot;The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights,&quot; said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh.</p><p align="justify">Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor.</p><p align="justify">Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug.</p><p align="justify">The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid.</p><p align="justify">Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property.</p><p align="justify">Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Indian patent rulings may face legal heat internationally -Soma Das | Im4change.org</title> <meta name="description" content=" -The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Indian patent rulings may face legal heat internationally -Soma Das</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Economic Times</div><p align="justify"><br />The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned.</p><p align="justify">An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists.</p><p align="justify">"The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights," said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh.</p><p align="justify">Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor.</p><p align="justify">Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug.</p><p align="justify">The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid.</p><p align="justify">Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property.</p><p align="justify">Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $cookies = [] $values = [ (int) 0 => 'text/html; charset=UTF-8' ] $name = 'Content-Type' $first = true $value = 'text/html; charset=UTF-8'header - [internal], line ?? Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
<head>
<link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 20268, 'title' => 'Indian patent rulings may face legal heat internationally -Soma Das', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times </div> <p align="justify"> <br /> The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. </p> <p align="justify"> An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists. </p> <p align="justify"> "The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights," said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh. </p> <p align="justify"> Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor. </p> <p align="justify"> Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug. </p> <p align="justify"> The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid. </p> <p align="justify"> Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property. </p> <p align="justify"> Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>', 'credit_writer' => 'The Economic Times, 11 April, 2013, http://economictimes.indiatimes.com/news/economy/policy/indian-patent-rulings-may-face-legal-heat-internationally/articleshow/19486296.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20409, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 20268, 'metaTitle' => 'LATEST NEWS UPDATES | Indian patent rulings may face legal heat internationally -Soma Das', 'metaKeywords' => 'generic drugs,medicines,patents,Health', 'metaDesc' => ' -The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade...', 'disp' => '<div align="justify">-The Economic Times</div><p align="justify"><br />The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned.</p><p align="justify">An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists.</p><p align="justify">"The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights," said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh.</p><p align="justify">Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor.</p><p align="justify">Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug.</p><p align="justify">The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid.</p><p align="justify">Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property.</p><p align="justify">Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 20268, 'title' => 'Indian patent rulings may face legal heat internationally -Soma Das', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times </div> <p align="justify"> <br /> The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. </p> <p align="justify"> An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists. </p> <p align="justify"> "The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights," said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh. </p> <p align="justify"> Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor. </p> <p align="justify"> Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug. </p> <p align="justify"> The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid. </p> <p align="justify"> Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property. </p> <p align="justify"> Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>', 'credit_writer' => 'The Economic Times, 11 April, 2013, http://economictimes.indiatimes.com/news/economy/policy/indian-patent-rulings-may-face-legal-heat-internationally/articleshow/19486296.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 20409, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 20268 $metaTitle = 'LATEST NEWS UPDATES | Indian patent rulings may face legal heat internationally -Soma Das' $metaKeywords = 'generic drugs,medicines,patents,Health' $metaDesc = ' -The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade...' $disp = '<div align="justify">-The Economic Times</div><p align="justify"><br />The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned.</p><p align="justify">An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists.</p><p align="justify">"The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights," said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh.</p><p align="justify">Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor.</p><p align="justify">Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug.</p><p align="justify">The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid.</p><p align="justify">Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property.</p><p align="justify">Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. </p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
![]() |
Indian patent rulings may face legal heat internationally -Soma Das |
-The Economic Times
An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon their investment rights under a free-trade agreement. The EU is pushing India to include this clause in their proposed free trade pact, claim health activists. "The pro-public health stance recently taken by Indian courts protecting against the abuse of multinational pharmaceutical companies, as well as potential future decisions by the government to issue price controls or compulsory licenses, would be threatened should India agree on an expansive definition of investment (in the India-EU FTA), which includes all forms of intellectual property rights," said Unni Karunakara, international president of Doctors Without Borders, in a letter to PM Manmohan Singh. Doctors Without Borders is a global medical humanitarian organisation working in over 60 countries. It is one of several health activists groups in the country that support lowering of prices of essential medicines to make them easily accessible to the poor. Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India, including that in the Glivec case, where the Supreme Court rejected Swiss firm Novartis' plea to grant a patent on its leukemia drug. The other countries that are already embroiled or have been threatened with international arbitration include Canada, Australia and Uruguay. In December, US drug innovator Eli Lilly said it would launch a legal offensive against the Canadian government under the North America Free Trade Agreement investor-state dispute mechanism. The drugmaker is seeking $100 million in compensation by challenging the decision of Canadian Courts that declared a patent on its drug Atomoxetine invalid. Indian drugmakers are already protesting proposed clauses in the final agreement, stipulating that mere suspicion of patent infringement by an Indian drugmaker could lead to seizure of the company's bank accounts and immovable property. Injunctions could also be issued against intermediaries and third parties, like suppliers, drug distributors and procurement agencies, for infringement of intellectual property rights. Commerce and Industry Minister Anand Sharma is scheduled to meet the EU Trade Commissioner, Karel De Gucht, in Brussels on April 15 to sort out the differences. |